| Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis P Alex, NC Zachos, T Nguyen, L Gonzales, TE Chen, LS Conklin, ... Inflammatory bowel diseases 15 (3), 341-352, 2009 | 869 | 2009 |
| Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function DS Shouval, A Biswas, JA Goettel, K McCann, E Conaway, NS Redhu, ... Immunity 40 (5), 706-719, 2014 | 579 | 2014 |
| Downregulation of Sodium Transporters and NHERF Proteins in IBD Patients and Mouse Colitis Models: PotentialContributors to IBD-associated Diarrhea S Sullivan, P Alex, T Dassopoulos, NC Zachos, C Iacobuzio-Donahue, ... Inflammatory bowel diseases 15 (2), 261-274, 2009 | 135 | 2009 |
| New serological biomarkers of inflammatory bowel disease X Li, L Conklin, P Alex World journal of gastroenterology: WJG 14 (33), 5115, 2008 | 107 | 2008 |
| Biofunctionalized gadolinium-containing prussian blue nanoparticles as multimodal molecular imaging agents MF Dumont, HA Hoffman, PRS Yoon, LS Conklin, SR Saha, JP Paglione, ... Bioconjugate chemistry 25 (1), 129-137, 2014 | 92 | 2014 |
| Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug LS Conklin, JM Damsker, EP Hoffman, WJ Jusko, PD Mavroudis, ... Pharmacological Research 136, 140-150, 2018 | 91 | 2018 |
| Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function EP Hoffman, BD Schwartz, LJ Mengle-Gaw, EC Smith, D Castro, JK Mah, ... Neurology 93 (13), e1312-e1323, 2019 | 90 | 2019 |
| Identification of pathway-specific serum biomarkers of response to glucocorticoid and infliximab treatment in children with inflammatory bowel disease CR Heier, AA Fiorillo, E Chaisson, H Gordish-Dressman, Y Hathout, ... Clinical and translational gastroenterology 7 (9), e192, 2016 | 61 | 2016 |
| Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study EC Smith, LS Conklin, EP Hoffman, PR Clemens, JK Mah, RS Finkel, ... PLoS medicine 17 (9), e1003222, 2020 | 60 | 2020 |
| Serum pharmacodynamic biomarkers for chronic corticosteroid treatment of children Y Hathout, LS Conklin, H Seol, H Gordish-Dressman, KJ Brown, ... Scientific reports 6 (1), 31727, 2016 | 52 | 2016 |
| Designing clinical trials in paediatric inflammatory bowel diseases: a PIBDnet commentary D Turner, AM Griffiths, D Wilson, DR Mould, RN Baldassano, RK Russell, ... Gut 69 (1), 32-41, 2020 | 48 | 2020 |
| Nutritional considerations in pediatric inflammatory bowel disease LS Conklin, M Oliva-Hemker Expert review of gastroenterology & hepatology 4 (3), 305-317, 2010 | 45 | 2010 |
| Minimal hepatic encephalopathy in children: evaluation with proton MR spectroscopy BR Foerster, LS Conklin, M Petrou, PB Barker, KB Schwarz American journal of neuroradiology 30 (8), 1610-1613, 2009 | 45 | 2009 |
| Disease-specific and glucocorticoid-responsive serum biomarkers for Duchenne Muscular Dystrophy Y Hathout, C Liang, M Ogundele, G Xu, SM Tawalbeh, UJ Dang, ... Scientific reports 9 (1), 12167, 2019 | 42 | 2019 |
| Medical malpractice in gastroenterology LS Conklin, C Bernstein, L Bartholomew, M Oliva–Hemker Clinical Gastroenterology and Hepatology 6 (6), 677-681, 2008 | 40 | 2008 |
| Serum miRNAs are pharmacodynamic biomarkers associated with therapeutic response in pediatric inflammatory bowel disease SK Batra, CR Heier, L Diaz-Calderon, CB Tully, AA Fiorillo, ... Inflammatory Bowel Diseases 26 (10), 1597-1606, 2020 | 36 | 2020 |
| Enhanced TH17 Responses in Patients with IL10 Receptor Deficiency and Infantile-onset IBD DS Shouval, L Konnikova, AE Griffith, SM Wall, A Biswas, L Werner, ... Inflammatory bowel diseases 23 (11), 1950-1961, 2017 | 34 | 2017 |
| Serum biomarkers of glucocorticoid response and safety in anti-neutrophil cytoplasmic antibody-associated vasculitis and juvenile dermatomyositis LS Conklin, PA Merkel, LM Pachman, H Parikh, S Tawalbeh, JM Damsker, ... Steroids 140, 159-166, 2018 | 32 | 2018 |
| Developmental pharmacodynamics and modeling in pediatric drug development LS Conklin, EP Hoffman, J van den Anker The Journal of Clinical Pharmacology 59, S87-S94, 2019 | 27 | 2019 |
| Serum biomarkers associated with baseline clinical severity in young steroid-naïve Duchenne muscular dystrophy boys UJ Dang, M Ziemba, PR Clemens, Y Hathout, LS Conklin, ... Human Molecular Genetics 29 (15), 2481-2495, 2020 | 26 | 2020 |
